Patient Satisfaction Following Multidisciplinary Cancer Care Assessment in Day Hospital: A Prospective Observational Study. (EVAQSAP-HDJ-BC)
Evaluation and Analysis of Patient Satisfaction Following Multidisciplinary Complex Assessment in Day Hospital: Determinants and Implications for Continuous Quality Improvement
This study aims to evaluate patient satisfaction following a multidisciplinary "complex assessment" conducted in a Day Hospital setting at the Centre Hospitalier de Martigues. This assessment is part of routine care for patients diagnosed with cancer and scheduled to receive injectable anticancer treatment.
During this assessment, patients meet several healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The objective is to identify patient-specific needs and improve coordination of care at an early stage of the treatment pathway.
This is a prospective observational study based on an anonymous satisfaction questionnaire distributed to eligible adult patients after completion of the Day Hospital assessment. The primary objective is to assess overall patient satisfaction. Secondary objectives include evaluating satisfaction by specialty, identifying factors associated with satisfaction, and assessing the Net Promoter Score (NPS).
The results of this study are expected to help identify strengths and areas for improvement in multidisciplinary care, enhance patient-centered care, and support continuous quality improvement in oncology practice.
Descripción general del estudio
Estado
Intervención / Tratamiento
Descripción detallada
Cancer care requires a multidisciplinary and patient-centered approach to address the complex medical, psychological, and social needs of patients. In this context, a "complex assessment" program has been implemented in the Day Hospital (HDJ) of the Centre Hospitalier de Martigues for patients with various types of cancer (breast, gynecological, urological, digestive, hematological, and pulmonary) prior to initiation of injectable anticancer therapies.
This program involves coordinated consultations with multiple healthcare professionals, including a pharmacist, dietitian, psychologist, social worker, and supportive care providers. The aim is to identify vulnerabilities, optimize supportive care, and improve the overall patient care pathway.
This study is designed as a prospective observational study evaluating patient satisfaction with this multidisciplinary intervention. All eligible adult patients who undergo the Day Hospital complex assessment are invited to complete an anonymous satisfaction questionnaire. The questionnaire includes items related to the quality of care, interactions with healthcare professionals, organization of care, and overall satisfaction, as well as a Net Promoter Score (NPS).
The primary endpoint is the proportion of patients reporting high overall satisfaction. Secondary endpoints include satisfaction levels by healthcare professional category, identification of determinants associated with satisfaction, and evaluation of the NPS according to demographic and clinical characteristics.
Statistical analyses will include descriptive statistics, univariate and multivariate analyses to identify factors associated with patient satisfaction. Results from this study will provide valuable insights into patient experience and contribute to the continuous improvement of multidisciplinary oncology care in a non-university hospital setting.
Tipo de estudio
Inscripción (Estimado)
Contactos y Ubicaciones
Estudio Contacto
- Nombre: Gwladys M'BOUNGOU Clinical study manager, Msc
- Número de teléfono: +33 0442432469
- Correo electrónico: gwladys.mboungou@ch-martigues.fr
Copia de seguridad de contactos de estudio
- Nombre: MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
- Número de teléfono: +33-04 42 43 27 56
- Correo electrónico: Gwenola.MARTIN@ch-martigues.fr
Ubicaciones de estudio
-
-
Bouches du Rhone
-
Martigues, Bouches du Rhone, Francia, 13500
- Reclutamiento
- Centre Hospitalier de Martigues
-
Contacto:
- Gwladys M'BOUNGOU Clinical study Manager, Master of Pharmacy (Pharmacolo
- Número de teléfono: +33 0442432469
- Correo electrónico: gwladys.mboungou@ch-martigues.fr
-
Contacto:
- MARTIN Gwenola healthcare manager of the day hospital, Diploma in Health Care Managem
- Número de teléfono: +33 +33-04 42 43 27 56
- Correo electrónico: Gwenola.MARTIN@ch-martigues.fr
-
Investigador principal:
- GERARDIN Eric, doctor
-
Sub-Investigador:
- CHEVALIER Thomas, doctor
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- Adult patients (≥ 18 years old)
- Patients undergoing a multidisciplinary "complex assessment" in a Day Hospital setting
- Patients diagnosed with cancer and scheduled to receive injectable anticancer treatment
- Ability to understand and complete the satisfaction questionnaire
- Patients who have been informed and have not opposed participation
Exclusion Criteria:
- Patients under 18 years of age
- Patients unable to complete the questionnaire (e.g., severe cognitive impairment or major language barrier)
- Patients who refuse participation
- Patients with incomplete Day Hospital complex assessment
- Patients under legal protection (guardianship or curatorship)
Patients under legal protection (guardianship or curatorship)
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
Cohortes e Intervenciones
Grupo / Cohorte |
Intervención / Tratamiento |
|---|---|
|
Patients undergoing multidisciplinary complex assessment in Day Hospital
Adult patients with cancer undergoing a multidisciplinary "complex assessment" in a Day Hospital setting prior to initiation of injectable anticancer treatment, including consultations with healthcare professionals and completion of a satisfaction questionnaire.
|
Routine multidisciplinary assessment conducted in a Day Hospital setting involving consultations with healthcare professionals (pharmacist, dietitian, psychologist, social worker, and supportive care providers) as part of standard oncology care.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Overall Patient Satisfaction
Periodo de tiempo: At completion of the Day Hospital assessment (within 1 month after assessment)
|
Proportion of patients reporting high overall satisfaction following the multidisciplinary complex assessment, measured using an anonymous satisfaction questionnaire.
|
At completion of the Day Hospital assessment (within 1 month after assessment)
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Estimado)
Finalización del estudio (Estimado)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 2024-A02062-45-EVAQSAP-HDJ-BC
- 2024-A02062-45 (Otro identificador: ANSM)
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Descripción del plan IPD
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Cáncer
-
Istanbul Aydın UniversityTerminado
-
Abramson Cancer Center of the University of PennsylvaniaTerminadoPaciente con cancerEstados Unidos
-
Peking Union Medical College HospitalTerminadoEncuesta | Estado nutricional | Paciente con cancerPorcelana
-
Northwestern UniversityGenzyme, a Sanofi CompanyRetiradoCANCER DE PROSTATAEstados Unidos
-
Ankara Medipol UniversityReclutamientoCuidados personales | Inmunoterapia | Manejo de síntomas | Paciente con cancerPavo
-
Fundacao ChampalimaudTerminado
-
University College London HospitalsTerminado
-
GenSpera, Inc.RetiradoCancer de prostata.Estados Unidos
-
University of Colorado, DenverColorado State UniversityRetiradoRealidad virtual | Diagnóstico por imagen | Educación del paciente | Paciente con cancerEstados Unidos
-
Dana-Farber Cancer InstituteTerminadoCancer de RIÑON | Cancer de prostata | Cáncer genitourinarioEstados Unidos
Ensayos clínicos sobre Multidisciplinary Complex Assessment
-
Seton Healthcare FamilyUniversity of Texas at AustinTerminadoCalidad de vida | Enfermedad crónica | Enfermedad crónicaEstados Unidos
-
Fabio Correia SampaioTerminado
-
Bispebjerg HospitalOdense University Hospital; Rigshospitalet, Denmark; Danish Cancer Society; Nordsjaellands... y otros colaboradoresTerminadoCuidados paliativosDinamarca
-
Coloplast A/STerminadoCalidad de vida | Papel de la enfermera | Estoma de colostomía | Estoma Ileostomía | Fuga del sitio del estomaDinamarca
-
MSDx, Inc.RetiradoEsclerosis múltipleEstados Unidos
-
University of ZurichTerminadoTrastorno de estrés postraumático (TEPT) | Trastorno de estrés postraumático complejo (CPTSD)Suiza
-
Centre Francois BaclesseTerminado
-
Bispebjerg HospitalDanish Cancer Society; Home care nursing in the Municipality of Gentofte; Home... y otros colaboradoresActivo, no reclutandoCuidados paliativosDinamarca
-
MSDx, Inc.TerminadoEsclerosis múltiple remitente recurrenteEstados Unidos
-
University of PennsylvaniaTerminado